The unpredictability of symptoms and apprehension associated with living with migraine is limiting mens’ lives, according to research from Griffith University’s Genomics Research Centre.
Although migraine is more common in women than men, about 6% of Australian men live with the debilitating neurological condition characterised by chronic headaches, sensitivity to light, visual symptoms and nausea.
Senior researcher Sharon Quinlan said the onset of migraine in males can be as early as eight years of age and many will have to manage the condition for life. There is currently no completely effective treatment or cure.
The research assessed quality of life in over 200 men with migraine compared to healthy men. Participants were average men managing their condition amidst jobs, family, and other commitments.
Physical functioning, energy levels, emotional wellbeing and general health were all poorer in men with migraine than those without.
"The reality is that if you have a migraine, you certainly can’t perform at your peak and sometimes you can’t perform at all," Ms Quinlan said.
She said the ability to study, play sport, work and even enjoy a social life could be compromised by migraine symptoms.
Not knowing when the next migraine could happen and the apprehension of having to deal with symptoms when migraine did strike, made it difficult for men to plan their lives.
As well as using medications to try and manage their symptoms, people often had to withdraw into a quiet, dark room to recover.
"Migraine isn’t life-threatening and doesn’t have the profile of many of those diseases, but it does limit people’s lives and also affects family members’ quality of life," Ms Quinlan said.
Source: Research Australia
Related stories:
Migraine increases risk of severe skin sensitivity and pain
People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing one’s head, combing one’s hair and wearing necklaces or earrings, compared to people with other types of headache, according to a study published in the April 22, 2008, issue of
Neurology, the medical journal of the American Academy of Neurology.
First detailed picture of migraine attack
Every eight adults in Sweden suffer from migraine. Using a new method, researchers at Göteborg have managed for the first time ever to provide a detailed picture of an untreated attack. This will be of great significance for the development of new forms of treatment. The findings are reported in a dissertation at the Sahgrenska Academy.
Gene may put women with migraine at increased risk of heart disease and stroke
Women who experience migraine with aura appear to be at an increased risk of heart disease and stroke if they have a certain gene, according to a study published in the July 30, 2008, online issue of
Neurology, the medical journal of the American Academy of Neurology.
Oxygen therapy might ease pain of migraine, cluster headaches
Two types of oxygen therapy could offer some relief to adults who suffer from disabling migraine and cluster headaches, according to a new research review from Australia.
Combination drug taken early relieves migraine symptoms
A combination drug taken within an hour after the start of a migraine is effective in relieving symptoms, according to research published in the July 8, 2008, issue of
Neurology, the medical journal of the American Academy of Neurology.
UVA researchers make pivotal breakthrough in alcohol addiction treatment
Alcoholism is a devastating disease in part because of the 'symptom' of heavy drinking but more so due to the extensive harm it causes physical organs, such as the heart and liver, as well as damage to an individual's psychosocial well-being that decreases quality of life.
Concentrating on different aspects of pain leads to breakthrough in migraine genetics
Migraine is the most common cause of episodic headache, and by far the most common neurological cause of a doctor’s visit. It affects some 15% of the population, including some 41 million people in Europe, and places a considerable burden on healthcare in both the developed and the developing world.
Sleep chemical central to effectiveness of deep brain stimulation
A brain chemical that makes us sleepy also appears to play a central role in the success of deep brain stimulation to ease symptoms in patients with Parkinson’s disease and other brain disorders. The surprising finding is outlined in a paper published online Dec. 23 in
Nature Medicine.